These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 10455199

  • 21. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
    Tumova S, Hatch BA, Law DJ, Bame KJ.
    Biochem J; 1999 Feb 01; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
    [Abstract] [Full Text] [Related]

  • 22. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    Miao HQ, Fritz TA, Esko JD, Zimmermann J, Yayon A, Vlodavsky I.
    J Cell Biochem; 1995 Feb 01; 57(2):173-84. PubMed ID: 7759555
    [Abstract] [Full Text] [Related]

  • 23. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.
    Olwin BB, Rapraeger A.
    J Cell Biol; 1992 Aug 01; 118(3):631-9. PubMed ID: 1379245
    [Abstract] [Full Text] [Related]

  • 24. Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican.
    Romarís M, Bassols A, David G.
    Biochem J; 1995 Aug 15; 310 ( Pt 1)(Pt 1):73-81. PubMed ID: 7544118
    [Abstract] [Full Text] [Related]

  • 25. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells.
    Skaletz-Rorowski A, Schmidt A, Breithardt G, Buddecke E.
    Arterioscler Thromb Vasc Biol; 1996 Aug 15; 16(8):1063-9. PubMed ID: 8696947
    [Abstract] [Full Text] [Related]

  • 26. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
    Bashkin P, Neufeld G, Gitay-Goren H, Vlodavsky I.
    J Cell Physiol; 1992 Apr 15; 151(1):126-37. PubMed ID: 1313817
    [Abstract] [Full Text] [Related]

  • 27. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.
    Fannon M, Forsten KE, Nugent MA.
    Biochemistry; 2000 Feb 15; 39(6):1434-45. PubMed ID: 10684625
    [Abstract] [Full Text] [Related]

  • 28. Purification of a basic fibroblast growth factor-binding proteoglycan from bovine cardiac plasma membrane.
    Ross CR, Kubinak S, Hale CC.
    Biochim Biophys Acta; 1993 Feb 09; 1145(2):219-26. PubMed ID: 8431453
    [Abstract] [Full Text] [Related]

  • 29. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
    Sperinde GV, Nugent MA.
    Biochemistry; 1998 Sep 22; 37(38):13153-64. PubMed ID: 9748322
    [Abstract] [Full Text] [Related]

  • 30. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor.
    Thompson K, Rabinovitch M.
    J Cell Physiol; 1996 Mar 22; 166(3):495-505. PubMed ID: 8600153
    [Abstract] [Full Text] [Related]

  • 31. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.
    Moscatelli D.
    J Biol Chem; 1992 Dec 25; 267(36):25803-9. PubMed ID: 1464594
    [Abstract] [Full Text] [Related]

  • 32. Basic fibroblast growth factor (bFGF) receptors decrease with luteal age in rat ovarian luteal cells: colocalization of bFGF receptors and bFGF in luteal cells.
    Asakai R, Tamura K, Eishi Y, Iwamoto M, Kato Y, Okamoto R.
    Endocrinology; 1993 Sep 25; 133(3):1074-84. PubMed ID: 7689947
    [Abstract] [Full Text] [Related]

  • 33. Binding of two growth factor families to separate domains of the proteoglycan betaglycan.
    Andres JL, DeFalcis D, Noda M, Massagué J.
    J Biol Chem; 1992 Mar 25; 267(9):5927-30. PubMed ID: 1556106
    [Abstract] [Full Text] [Related]

  • 34. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix.
    Benezra M, Vlodavsky I, Ishai-Michaeli R, Neufeld G, Bar-Shavit R.
    Blood; 1993 Jun 15; 81(12):3324-31. PubMed ID: 8507869
    [Abstract] [Full Text] [Related]

  • 35. Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate.
    Richardson TP, Trinkaus-Randall V, Nugent MA.
    J Biol Chem; 1999 May 07; 274(19):13534-40. PubMed ID: 10224122
    [Abstract] [Full Text] [Related]

  • 36. Degradation of cell surface heparan sulfates decreases the high affinity binding of basic FGF to endothelial cells, but not to FRTL-5 rat thyroid cells.
    Emoto N, Isozaki O, Ohmura E, Shizume K, Tsushima T, Demura H.
    Thyroid; 1995 Dec 07; 5(6):455-60. PubMed ID: 8808095
    [Abstract] [Full Text] [Related]

  • 37. Transforming growth factor-beta 1 increases internalization of basic fibroblast growth factor by smooth muscle cells: implication of cell-surface heparan sulphate proteoglycan endocytosis.
    Berrou E, Quarck R, Fontenay-Roupie M, Lévy-Toledano S, Tobelem G, Bryckaert M.
    Biochem J; 1995 Oct 15; 311 ( Pt 2)(Pt 2):393-9. PubMed ID: 7487873
    [Abstract] [Full Text] [Related]

  • 38. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC, Rahimi N, Forsten-Williams K, Nugent MA.
    Circ Res; 2004 Feb 20; 94(3):316-23. PubMed ID: 14684627
    [Abstract] [Full Text] [Related]

  • 39. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding.
    Roghani M, Mansukhani A, Dell'Era P, Bellosta P, Basilico C, Rifkin DB, Moscatelli D.
    J Biol Chem; 1994 Feb 11; 269(6):3976-84. PubMed ID: 8307953
    [Abstract] [Full Text] [Related]

  • 40. Heparan sulfate proteoglycan promotes fibroblast growth factor-2 function for ischemic heart repair.
    Shi J, Fan C, Zhuang Y, Sun J, Hou X, Chen B, Xiao Z, Chen Y, Zhan Z, Zhao Y, Dai J.
    Biomater Sci; 2019 Dec 01; 7(12):5438-5450. PubMed ID: 31642823
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.